Stockreport

RegenX Bio Gene Therapy Shows Early Promise In Macular Degeneration [Forbes]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Shutterstock A gene therapy being developed by RegenX Bio of Rockville, MD, showed early promise against wet macular degeneration, a leading cause [Read more]